Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunosuppressed Host”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02544685
What this trial is testing

Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients

Who this might be right for
Febrile NeutropeniaNeutropeniaInfection in an Immunocompromised Host+1 more
S&D Pharma SK s.r.o. 120
Not applicableStudy completedNCT07690943
What this trial is testing

Evaluation of the Safety and Efficacy of Autologous COVID-19 Antigen Specific T Cell in Prolonged SARS-CoV-2 Patients

Who this might be right for
COVID-19COVID-19 (SARS-CoV-2 Infection)
LucasBio 13
Not applicableUnknownNCT06223100
What this trial is testing

Efficacy and Safety of the Combination Therapy Based on Eravacycline in Immunocompromised Hosts With MDROS Infection

Who this might be right for
Immune Dysregulation Disorder
Sichuan Provincial People's Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01687192
What this trial is testing

Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.

Who this might be right for
TransplantationSystemic Lupus ErythematosusSystemic Immune Disease
University Hospital, Bordeaux 37
Early research (Phase 1)Looking for participantsNCT04691622
What this trial is testing

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

Who this might be right for
Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)
Children's National Research Institute 48
Early research (Phase 1)Temporarily pausedNCT00160992
What this trial is testing

Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients

Who this might be right for
Melanoma
University of Lausanne Hospitals 6
Not applicableEnded earlyNCT05956795
What this trial is testing

Surveillance of Regional Nodal Basins in Patients With Primary High Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Cutaneous Squamous Cell Carcinoma of the Head and Neck
Johns Hopkins University 1
Large-scale testing (Phase 3)Study completedNCT02058589
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults 18 Years of Age or Older With Renal Transplant

Who this might be right for
Herpes Zoster
GlaxoSmithKline 265
Post-approval studies (Phase 4)UnknownNCT01017172
What this trial is testing

Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients

Who this might be right for
HIV-1 InfectionCancerImmunosuppression
Goethe University 500
Testing effectiveness (Phase 2)Looking for participantsNCT02532452
What this trial is testing

Third Party Viral Specific T-cells (VSTs)

Who this might be right for
Viral InfectionViral ReactivationInfection in an Immunocompromised Host
Children's Hospital Medical Center, Cincinnati 1,000
Not applicableLooking for participantsNCT01306084
What this trial is testing

Viral Infections in Healthy and Immunocompromised Hosts

Who this might be right for
Anogenital HerpesCOVID-19Herpes Labialis
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Not applicableUnknownNCT04511429
What this trial is testing

COVID-19 in Immunosuppressed Children

Who this might be right for
Infections, CoronavirusKidney TransplantationLiver Transplantation+2 more
D'Or Institute for Research and Education 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT07357103
What this trial is testing

Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)

Who this might be right for
PneumocystisPneumocystis InfectionPneumocystis Carinii Infection+5 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 416
Not applicableStudy completedNCT00904579
What this trial is testing

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

Who this might be right for
Immunocompromised HostOrgan TransplantationCancer
National Cancer Institute (NCI) 19,929,901
Not applicableStudy completedNCT01066169
What this trial is testing

Vaccination Response in ImmunoCompromised Host. Immune Response After Vaccination Against Pandemic A/H1N1 Influenza

Who this might be right for
HIV
Leiden University Medical Center 104
Post-approval studies (Phase 4)Looking for participantsNCT07426484
What this trial is testing

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Who this might be right for
Cutaneous Squamous Cell CarcinomaSkin Cancer
Dana-Farber Cancer Institute 80
Not applicableStudy completedNCT00561639
What this trial is testing

Benefit of SeptiFast Multiplex PCR in the Etiologic Diagnosis and Therapeutic Approach for Onco-hematology Patients Presenting Sepsis

Who this might be right for
Hematologic DiseasesSepsis
University Hospital, Grenoble 76
Not applicableUnknownNCT00285441
What this trial is testing

Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active Tuberculosis

Who this might be right for
TuberculosisHIV InfectionsRheumatoid Arthritis
Hvidovre University Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00189267
What this trial is testing

Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Who this might be right for
Actinic Keratosis
MEDA Pharma GmbH & Co. KG 45
Large-scale testing (Phase 3)Study completedNCT00159822
What this trial is testing

Voriconazole For Chronic Bronchopulmonary Aspergillosis

Who this might be right for
Aspergillosis
Pfizer 48
Next Page